{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:25:31Z","timestamp":1792275931881,"version":"4.4.0"},"reference-count":22,"publisher":"Scientific Scholar","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,7]]},"abstract":"\n Aim and Objectives:<\/jats:title>\n The aim of this study is to assess the added value of hybrid fluorodeoxyglucose (FDG) positron emission tomography\/computed tomography (PET\/CT) in the evaluation of extranodal involvement in patients with lymphoma in comparison to contrast-enhanced CT (CECT).<\/jats:p>\n <\/jats:sec>\n \n Patients and Methods:<\/jats:title>\n All patients had lymphoma, proved by histopathological and immunophenotyping examinations. They underwent CECT and F-18 FDG PET\u2013CT studies. Both CECT and PET\/CT studies were done within 30 days.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n The study included 144 patients 92 (63.9%) males and 52 (36.1%) females with mean age 49.3 years (range 18\u201380 years). A total of 102 (70.8%) patients had non-Hodgkin lymphoma and 42 patients (18.1%) had Hodgkin disease, diffuse large B-cell lymphoma subtype had the highest prevalence 52.8% (76\/144), whereas lymphocytic predominance was the least prevalent 1.4% (2\/144) followed by mucosa-associated lymphoid tissue lymphoma 2.8% (4\/144) and small lymphocytic type 4.2% (6\/144), mixed cellularity (MC), T-cell, and follicular type were equally distributed 6.9% (10\/144 each). The lung was the most common site as it was involved in 34 patients followed by bone and bone marrow 32 patients, spleen 18, liver 16, nasopharynx 8, stomach 6, cutaneous and subcutaneous tissue 6, peritoneum, cecum, small intestine, brain, and intramuscular four patients each. However, the parotid and pancreas were the least common sites two patients each. The overall sensitivity, specificity PPV, NPV, and accuracy of PET\/CT and CECT are 97%, 20% 94.2%, 33.3% and 91.7% and 89.6%, 60%, 96.8%, 30% and 87.5%, respectively.<\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n F-18 FDG-PET\/CT can accurately monitor the extranodal lymphoma, it can detect metabolically-active lesions without CT structural changes and identify viable tumor in normal size lymph nodes. FDG-PET\/CT is more effective than CECT in evaluating extra nodal lymphomatous infiltration, especially in the spleen, bone, and bone marrow.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/ijnm.ijnm_47_18","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T08:47:56Z","timestamp":1717058876000},"page":"183-189","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["F-18 FDG PET-CT Versus Contrast Enhanced CT in Detection of Extra Nodal Involvement in Patients with Lymphoma"],"prefix":"10.25259","volume":"33","author":[{"given":"Aboelmagd","family":"Alnouby","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, International Medical Center, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibraheem Mansour","family":"Ibraheem Nasr","sequence":"additional","affiliation":[{"name":"Department of Oncology and Nuclear Medicine, Nuclear Medicine Unit, Faculty of Medicine, Zagazig University, Zagazig, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Radiology, Nuclear Medicine Unit, Faculty of Medicine, Zagazig University, Zagazig, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Rezk","sequence":"additional","affiliation":[{"name":"Department of Radiology, National Cancer Institute, Cairo University, Giza, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"R1-20250605","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1148\/rg.301095088","article-title":"FDG PET\/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease","volume":"30","author":"Paes","year":"2010","journal-title":"Radiographics"},{"key":"R2-20250605","doi-asserted-by":"crossref","first-page":"W384","DOI":"10.2214\/AJR.10.5692","article-title":"Whole-body diffusion-weighted imaging: The added value to whole-body MRI at initial diagnosis of lymphoma","volume":"197","author":"Gu","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"R3-20250605","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.2214\/ajr.182.6.1821579","article-title":"PET-CT of extranodal lymphoma","volume":"182","author":"Metser","year":"2004","journal-title":"AJR Am J Roentgenol"},{"key":"R4-20250605","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.thj.6200154","article-title":"Increasing incidence and descriptive epidemiology of extranodal non-Hodgkin lymphoma in parts of England and wales","volume":"3","author":"Gurney","year":"2002","journal-title":"Hematol J"},{"key":"R5-20250605","first-page":"185","article-title":"Fluorine-18 fluorodeoxyglucose PET-CT for extranodal staging of non-Hodgkin and Hodgkin lymphoma","volume":"20","author":"\u00d6m\u00fcr","year":"2014","journal-title":"Diagn Interv Radiol"},{"key":"R6-20250605","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1148\/radiology.206.2.9457202","article-title":"Extranodal malignant lymphoma: Detection with FDG PET versus CT","volume":"206","author":"Moog","year":"1998","journal-title":"Radiology"},{"key":"R7-20250605","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1148\/radiol.2252011568","article-title":"PET diagnostic accuracy: Improvement with in-line PET-CT system: Initial results","volume":"225","author":"Hany","year":"2002","journal-title":"Radiology"},{"key":"R8-20250605","first-page":"1","article-title":"Role of 18F-FDG PET versus CT scan in evaluation of extranodal lymphoma","volume":"7","author":"El-Haddad","year":"2015","journal-title":"J Nucl Med Radiol Ther"},{"key":"R9-20250605","first-page":"1637","article-title":"PET\/CT in initial staging and therapy response assessment of lymphoma","volume":"47","author":"Omar","year":"2016","journal-title":"Egypt J Radiol Nucl Med"},{"key":"R10-20250605","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/annonc\/mdj024","article-title":"Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET\/CT era?","volume":"17","author":"Raanani","year":"2006","journal-title":"Ann Oncol"},{"key":"R11-20250605","first-page":"42","article-title":"Extranodal involvement in lymphoma \u2013 A pictorial essay and retrospective analysis of 281 PET\/CT studies","volume":"2","author":"Das","year":"2014","journal-title":"Asia Ocean J Nucl Med Biol"},{"key":"R12-20250605","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1093\/annonc\/mdp030","article-title":"High SUV uptake on FDG-PET\/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET\/CT staging in lymphoma","volume":"20","author":"Ngeow","year":"2009","journal-title":"Ann Oncol"},{"key":"R13-20250605","first-page":"39","article-title":"PET\/CT of extranodal involvement in lymphoma","volume":"1","author":"Parra","year":"2012","journal-title":"Imagenes"},{"key":"R14-20250605","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/hon.782","article-title":"Different histopathological subtypes of Hodgkin lymphoma show significantly different levels of FDG uptake","volume":"24","author":"Hutchings","year":"2006","journal-title":"Hematol Oncol"},{"key":"R15-20250605","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2214\/AJR.07.3146","article-title":"Abdominal manifestations of extranodal lymphoma: Spectrum of imaging findings","volume":"191","author":"Lee","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"R16-20250605","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.rcl.2008.04.001","article-title":"Imaging of abdominal lymphoma","volume":"46","author":"Anis","year":"2008","journal-title":"Radiol Clin North Am"},{"key":"R17-20250605","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.rcl.2008.03.002","article-title":"Imaging of gastrointestinal lymphoma","volume":"46","author":"Gollub","year":"2008","journal-title":"Radiol Clin North Am"},{"key":"R18-20250605","doi-asserted-by":"crossref","first-page":"483069","DOI":"10.5402\/2013\/483069","article-title":"Abdominal manifestations of lymphoma: Spectrum of imaging features","volume":"2013","author":"Manzella","year":"2013","journal-title":"ISRN Radiol"},{"key":"R19-20250605","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1148\/rg.236025056","article-title":"Primary bone lymphoma: Radiographic-MR imaging correlation","volume":"23","author":"Krishnan","year":"2003","journal-title":"Radiographics"},{"key":"R20-20250605","first-page":"1609","article-title":"18F FDG PET-CT in extranodal non-Hodgkin lymphoma","volume":"57","author":"Sollini","year":"2016","journal-title":"J Nucl Med"},{"key":"R21-20250605","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11307-009-0200-9","article-title":"Comparison of CT, PET, and PET\/CT for staging of patients with indolent non-Hodgkin's lymphoma","volume":"11","author":"Fueger","year":"2009","journal-title":"Mol Imaging Biol"},{"key":"R22-20250605","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ejrnm.2012.12.008","article-title":"Potential impact of PET\/CT on the initial staging of lymphoma","volume":"44","author":"Kamel","year":"2013","journal-title":"Egypt J Radiol Nucl Med"}],"container-title":["Indian Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01699315-201833030-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T07:35:25Z","timestamp":1779694525000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijnm.co.in\/f-18-fdg-pet-ct-versus-contrast-enhanced-ct-in-detection-of-extra-nodal-involvement-in-patients-with-lymphoma\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.4103\/ijnm.ijnm_47_18","relation":{},"ISSN":["0972-3919","0974-0244"],"issn-type":[{"value":"0972-3919","type":"print"},{"value":"0974-0244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7]]}}}